levetiracetam and Stiff-Person-Syndrome

levetiracetam has been researched along with Stiff-Person-Syndrome* in 2 studies

Trials

1 trial(s) available for levetiracetam and Stiff-Person-Syndrome

ArticleYear
Levetiracetam in stiff-person syndrome.
    Journal of neurology, 2008, Volume: 255, Issue:11

    We studied the effects of oral levetiracetam (LEV) (500 mg twice daily) in three women with stiff-person syndrome in a single-blind, placebo-controlled study. The severity of muscle rigidity and of paroxysmal symptoms was assessed by EMG and clinically by a rating scale of 0-4 and by the Patients Global Impressions Scale. LEV was well tolerated. On active treatment all patients improved as assessed by any of the objective or subjective outcome measures. No response was noticed on placebo. Our data indicate that in patients with SPS, LEV is well tolerated and has a therapeutic role in the management of both muscle stiffness and life-threatening paroxysmal respiratory spasms.

    Topics: Aged; Anticonvulsants; Electromyography; Female; Humans; Levetiracetam; Middle Aged; Muscle Rigidity; Muscle, Skeletal; Neurologic Examination; Piracetam; Respiration; Single-Blind Method; Spasm; Stiff-Person Syndrome

2008

Other Studies

1 other study(ies) available for levetiracetam and Stiff-Person-Syndrome

ArticleYear
Levetiracetam improves paroxysmal symptoms in a patient with stiff-person syndrome.
    Neurology, 2004, Jan-27, Volume: 62, Issue:2

    Topics: Female; GABA Agonists; Humans; Immunoglobulins, Intravenous; Levetiracetam; Middle Aged; Muscle Spasticity; Piracetam; Stiff-Person Syndrome; Valproic Acid

2004